carnitine has been researched along with Cancer of Pancreas in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To enable the early diagnosis of pancreatic cancer, the search for and definition of reliable biomarkers remain a subject of great interest, with the specificity and sensitivity of the currently used biomarkers being below the required values." | 1.48 | Chiroptical spectroscopy and metabolomics for blood-based sensing of pancreatic cancer. ( Bunganič, B; Habartová, L; Setnička, V; Syslová, K; Tatarkovič, M; Vondroušová, J; Zavoral, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wada, Y | 1 |
| Okano, K | 1 |
| Sato, K | 1 |
| Sugimoto, M | 1 |
| Shimomura, A | 1 |
| Nagao, M | 1 |
| Matsukawa, H | 1 |
| Ando, Y | 1 |
| Suto, H | 1 |
| Oshima, M | 1 |
| Kondo, A | 1 |
| Asano, E | 1 |
| Kishino, T | 1 |
| Kumamoto, K | 1 |
| Kobara, H | 1 |
| Kamada, H | 1 |
| Masaki, T | 1 |
| Soga, T | 1 |
| Suzuki, Y | 1 |
| Wang, Y | 2 |
| Yu, T | 1 |
| Zhou, Y | 2 |
| Wang, S | 1 |
| Zhou, X | 1 |
| Wang, L | 1 |
| Ou, T | 1 |
| Chen, Y | 1 |
| Zhang, H | 1 |
| Fan, X | 1 |
| Chen, P | 1 |
| Gonzalez, FJ | 1 |
| Yu, A | 1 |
| Huang, P | 1 |
| Huang, M | 1 |
| Bi, H | 1 |
| Habartová, L | 1 |
| Bunganič, B | 1 |
| Tatarkovič, M | 1 |
| Zavoral, M | 1 |
| Vondroušová, J | 1 |
| Syslová, K | 1 |
| Setnička, V | 1 |
| Uchida, D | 1 |
| Takaki, A | 1 |
| Ishikawa, H | 1 |
| Tomono, Y | 1 |
| Kato, H | 1 |
| Tsutsumi, K | 1 |
| Tamaki, N | 1 |
| Maruyama, T | 1 |
| Tomofuji, T | 1 |
| Tsuzaki, R | 1 |
| Yasunaka, T | 1 |
| Koike, K | 1 |
| Matsushita, H | 1 |
| Ikeda, F | 1 |
| Miyake, Y | 1 |
| Shiraha, H | 1 |
| Nouso, K | 1 |
| Yoshida, R | 1 |
| Umeda, Y | 1 |
| Shinoura, S | 1 |
| Yagi, T | 1 |
| Fujiwara, T | 1 |
| Morita, M | 1 |
| Fukushima, M | 1 |
| Yamamoto, K | 1 |
| Okada, H | 1 |
| Kraft, M | 1 |
| Kraft, K | 1 |
| Gärtner, S | 1 |
| Mayerle, J | 1 |
| Simon, P | 1 |
| Weber, E | 1 |
| Schütte, K | 1 |
| Stieler, J | 1 |
| Koula-Jenik, H | 1 |
| Holzhauer, P | 1 |
| Gröber, U | 1 |
| Engel, G | 1 |
| Müller, C | 1 |
| Feng, YS | 1 |
| Aghdassi, A | 1 |
| Nitsche, C | 1 |
| Malfertheiner, P | 1 |
| Patrzyk, M | 1 |
| Kohlmann, T | 1 |
| Lerch, MM | 1 |
| Gross, MD | 1 |
| Whitty, AJ | 1 |
| Foà, PP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer[NCT02681601] | 2 participants (Actual) | Interventional | 2016-07-19 | Terminated (stopped due to low accrual) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for carnitine and Cancer of Pancreas
| Article | Year |
|---|---|
L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial.
Topics: Aged; Body Composition; Body Mass Index; Cachexia; Carnitine; Dietary Supplements; Double-Blind Meth | 2012 |
5 other studies available for carnitine and Cancer of Pancreas
| Article | Year |
|---|---|
Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer.
Topics: Antigens, CD; Carcinoma, Pancreatic Ductal; Carnitine; Chemoradiotherapy; Glutathione; Humans; Neoad | 2022 |
Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer.
Topics: Antigens, CD; Carcinoma, Pancreatic Ductal; Carnitine; Chemoradiotherapy; Glutathione; Humans; Neoad | 2022 |
Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer.
Topics: Antigens, CD; Carcinoma, Pancreatic Ductal; Carnitine; Chemoradiotherapy; Glutathione; Humans; Neoad | 2022 |
Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer.
Topics: Antigens, CD; Carcinoma, Pancreatic Ductal; Carnitine; Chemoradiotherapy; Glutathione; Humans; Neoad | 2022 |
Carnitine palmitoyltransferase 1C contributes to progressive cellular senescence.
Topics: Animals; Carcinogenesis; Carcinoma; Carnitine; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; C | 2020 |
Chiroptical spectroscopy and metabolomics for blood-based sensing of pancreatic cancer.
Topics: Aged; Biomarkers, Tumor; Carnitine; Case-Control Studies; Circular Dichroism; Discriminant Analysis; | 2018 |
Oxidative stress balance is dysregulated and represents an additional target for treating cholangiocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antioxidants; Carnitine; Cholangiocarcinoma; Disease Models | 2016 |
Respiratory activity of mitochondria isolated from a transplantable islet-cell tumor and from the liver of tumor-bearing hamsters.
Topics: Adenoma, Islet Cell; Adenosine Diphosphate; Animals; Blood Glucose; Carnitine; Cricetinae; Culture M | 1972 |